Biointelect Overview
- Founded
-
2011

- Status
-
Private
- Employees
-
21

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Biointelect General Information
Description
Provider of biopharmaceutical consulting services intended to develop and drive strategy. The company's services conduct detailed market evaluations and define optimum clinical, regulatory, reimbursement and market-entry strategies, enabling clients to identify opportunities and reduce risk as well as optimize commercial results for their bio-pharmaceutical product or medical device.
Contact Information
Website
www.biointelect.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Other Industries
Consulting Services (B2B)
Biotechnology
Primary Office
- 139 Macquarie Street
- Suite 5.02, Level 5
- Sydney, New South Wales 2000
- Australia
+61 1300 000 000
Biointelect Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Biointelect Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Max Howell | Chief Financial Officer | ||
Jennifer Herz | Managing Director & Founder | ||
Trina Thompson | Finance Manager |
Biointelect Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000000 | Biointelect | Chairman & Advisor | 000 0000 |
0000 0000 | Biointelect | Board Member | 000 0000 |
Biointelect Signals
Biointelect Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|